Coronary Atherosclerosis and Interventional Cardiology

Marco Antonio Peña-Duque1, José Luis Romero-Ibarra1, Manuel Ben Adoniram Gaxiola-Macías1

  • 1Interventional Cardiology Department, National Institute of Cardiology, Ignacio Chávez, Tlalpan, Mexico City, Mexico.

Insights

Atherosclerosis, a chronic inflammatory condition, starts with endothelial dysfunction and can lead to myocardial infarction. New techniques allow for plaque characterization and tailored treatments for coronary artery disease.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Pathophysiology

Background:

  • Atherosclerosis initiates with endothelial dysfunction, potentially causing thrombotic occlusion and myocardial infarction.
  • Coronary artery disease involves complex inflammatory processes and hemodynamic alterations.
  • Vulnerable plaque identification is crucial for predicting adverse cardiac events.

Purpose of the Study:

  • To review current evidence on atherosclerosis, vulnerable plaque, and coronary hemodynamics.
  • To discuss state-of-the-art catheterization techniques for evaluating coronary stenosis.
  • To highlight advancements in characterizing atherosclerotic plaques for patient management.

Main Methods:

  • Review of recent scientific literature on atherosclerosis and coronary artery disease.
  • Analysis of hemodynamic principles in the context of coronary stenosis.
  • Description of current interventional cardiology techniques for plaque assessment.

Main Results:

  • Atherosclerosis is a chronic inflammatory condition affecting the coronary arteries.
  • Vulnerable plaques and hemodynamic changes are key factors in coronary events.
  • Advanced catheterization techniques enable detailed plaque characterization.

Conclusions:

  • Current interventional cardiology methods allow for effective characterization of atherosclerotic plaques.
  • Personalized treatment selection for coronary artery disease is increasingly feasible.
  • Understanding atherosclerosis pathophysiology aids in managing patients at risk for myocardial infarction.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
523
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
349
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.4K
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
650
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
347
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
776